In colorectal cancer, aberrant expression of TRIP13 contributed markedly to the aggressive phenotype of cancer cells, and its overexpression induced the downregulation of miR-129-5p and miR-4693-5p [64,65]. Here, TRIP13 is linked to colorectal cancer.